Genetic Analysis Market Forecast Highlights Expansion From $11.62 Billion To $18.75 Billion Through 2030
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Genetic Analysis Market Size, Value And Growth Trends Through 2030
The genetic analysis market has experienced swift expansion in recent times. Projections indicate an increase from $10.29 billion in 2025 to $11.63 billion in 2026, reflecting a compound annual growth rate (CAGR) of 13.0%. Past growth is largely linked to factors such as the constrained accessibility of high-throughput sequencing platforms, dependence on traditional genetic testing approaches, heightened awareness regarding genetic disorders, greater funding for research laboratories, and a growing number of diagnostic facilities.
The genetic analysis market is projected to experience significant expansion in the coming years, reaching an estimated $18.75 billion by 2030, driven by a robust compound annual growth rate (CAGR) of 12.7%. This forecasted growth is fueled by key factors including progress in next-generation sequencing (NGS) and real-time PCR technologies, the rise of cloud-based platforms for genomic data, a growing emphasis on personalized medicine, heightened government support for genetic disease screening initiatives, and the incorporation of artificial intelligence along with bioinformatics tools into diagnostic processes. Key trends shaping this period involve the broadening use of NGS and PCR-based genetic testing, increased uptake of pharmacogenomic testing to tailor treatments, expanded prenatal and newborn genetic screening programs, a stronger focus on genetic diagnostics for rare diseases and cancer, and the seamless integration of bioinformatics with genomic data analysis tools.
Download A Free Sample Report For Comprehensive Market Insights:
Genetic Analysis Market Expansion Drivers: What Is Shaping Future Growth?
The rising incidence of cancer is anticipated to drive the expansion of the genetic analysis market in the foreseeable future. Cancer is characterized by the uncontrolled growth of certain body cells, which can potentially invade other regions. The surge in cancer cases is linked to an aging population, since older individuals are more prone to accumulating genetic mutations and experiencing prolonged exposure to environmental and lifestyle risk factors that foster cancer development. Genetic analysis plays a valuable role in cancer care by identifying specific genetic mutations responsible for the disease, enabling physicians to prescribe targeted therapies that tend to be more effective and produce fewer adverse effects. For example, in May 2025, a report from the National Cancer Institute (NCI)—a US-based agency focused on cancer research and training—indicated that approximately 20 million people worldwide were newly diagnosed with cancer in 2022, with around 9.7 million succumbing to the disease. Projections suggest that by 2050, the annual count of new cancer cases could climb to 33 million, while cancer-related deaths are predicted to increase to 18.2 million. Consequently, the growing number of cancer cases is fueling the advancement of the genetic analysis market.
Genetic Analysis Market Segment Analysis: What Are The Major Market Categories?
The genetic analysis market covered in this report is segmented –
1) By Product: Reagents And Kits, Instruments, Software
2) By Test: Predictive Genetic Testing, Carrier Testing, Prenatal And Newborn Testing, Disease Diagnostic Testing, Pharmacogenomic Testing, Other Tests
3) By Technology: Next-Generation Sequencing (NGS), Real-Time PCR System, Other Technologies
4) By Application: Cancer, Genetic Diseases, Cardiovascular Diseases, Rare Diseases, Infectious Diseases, Other Applications
5) By End-Use: Hospitals, Research And Development Laboratories, Diagnostic Centers, Other End-Uses
Subsegments:
1) By Reagents And Kits: DNA Extraction Kits, RNA Extraction Kits, PCR Reagents, Sequencing Reagents, Library Preparation Kits, Electrophoresis Reagents, Microarray Kits, Genotyping Assay Kits, Target Enrichment Kits, Nucleic Acid Labeling Kits
2) By Instruments: DNA Sequencers, PCR Machines, Microarray Scanners, Electrophoresis Systems, Real-Time PCR Systems, Automated Sample Preparation Systems, Genetic Analyzers, Bioanalyzers, Fragment Analyzers, Next-Generation Sequencing (NGS) Platforms
3) By Software: Data Analysis Software, Bioinformatics Tools, Laboratory Information Management Systems (LIMS), Genomic Data Interpretation Software, DNA Sequence Alignment Tools, Variant Annotation Software, Clinical Decision Support Software, Cloud-Based Genomic Platforms, Workflow Management Software, Data Visualization Tools
Genetic Analysis Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Key players in the genetic analysis market are prioritizing the creation of innovative tools, particularly genetic testing solutions, to facilitate early monitoring or preventive actions. These genetic testing solutions involve examining an individual’s DNA to identify alterations or variations in genes that could be connected to inherited traits or specific health conditions. For example, in June 2023, Devyser, a diagnostic kit developer based in Sweden, introduced Devyser LynchFAP and Devyser BRCA PALB2, two genetic testing solutions aimed at hereditary cancer. Devyser LynchFAP is distinguished by its comprehensive approach to analyzing PMS2 and nine other genes associated with hereditary colorectal cancer, effectively resolving the challenge of differentiating PMS2 from its pseudogene PMS2CL, and it holds the distinction of being the first commercial kit tailored for precise PMS2 gene analysis. Meanwhile, Devyser BRCA PALB2 is designed for targeted detection of genetic variants in BRCA1, BRCA2, and PALB2, which are critical genes linked to an elevated risk of breast and ovarian cancer, and its straightforward design enables seamless incorporation into laboratory workflows while facilitating analysis of DNA from both blood and tumor samples in a single assay.
Genetic Analysis Market Leading Companies Driving Competitive Growth
Major companies operating in the genetic analysis market are Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Quest Diagnostics Inc., Illumina Inc., PerkinElmer Inc., BioRad Laboratories Inc., Qiagen NV, Oxford Nanopore Technologies Plc, 23andMe Inc., ELITech Group, MyHeritage Ltd., Dante Labs Inc., AutoGenomics Inc., IntegraGen SA, Family Tree DNA, 24 genetics, Centrillion Biosciences Inc., DNA Worldwide Group Ltd., Genebase.
Access The Complete Genetic Analysis Market Report:
Genetic Analysis Market Regional Outlook: Where Are The Largest Opportunities Located?
North America was the largest region in the genetic analysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the genetic analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
